Expand / Collapse search
Watch TV
Menu

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.

Medications

Bayer to bring 5 mid-stage drugs into Phase III by 2015

By Reuters
Published | Updated
BAYER/

The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011. REUTERS/Fabrizio Bensch (Copyright Reuters 2013)

German drugmaker Bayer said it aims to bring its five most advanced mid-stage drug development projects into the third and last phase of testing on humans by 2015.

The five experimental drugs in the areas of oncology, cardiology and women's health are currently in Phase I and II of testing, Bayer said in a statement on Tuesday.

Bayer executives will make presentations to analysts later on Tuesday.